BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37495899)

  • 1. Medication treatment for opioid use disorder among rural primary care patients.
    Hser YI; Zhu Y; Baldwin LM; Mooney LJ; Saxon AJ
    J Rural Health; 2024 Jan; 40(1):195-199. PubMed ID: 37495899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of an intervention to implement provision of opioid use disorder medication among patients with and without co-occurring substance use disorders.
    Frost MC; Malte CA; Hawkins EJ; Glass JE; Hallgren KA; Williams EC
    J Subst Use Addict Treat; 2023 Dec; 155():209175. PubMed ID: 37751798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-occurring substance use disorders among patients with opioid use disorder in rural primary care clinics.
    Zhu Y; Baldwin LM; Mooney LJ; Saxon AJ; Kan E; Hser YI
    J Subst Use Addict Treat; 2024 Mar; 158():209269. PubMed ID: 38097045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accessibility to Medication for Opioid Use Disorder After Interventions to Improve Prescribing Among Nonaddiction Clinics in the US Veterans Health Care System.
    Hawkins EJ; Malte CA; Gordon AJ; Williams EC; Hagedorn HJ; Drexler K; Blanchard BE; Burden JL; Knoeppel J; Danner AN; Lott A; Liberto JG; Saxon AJ
    JAMA Netw Open; 2021 Dec; 4(12):e2137238. PubMed ID: 34870679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Medication for Opioid Use Disorder Among US Adolescents and Adults With Need for Opioid Treatment, 2019.
    Mauro PM; Gutkind S; Annunziato EM; Samples H
    JAMA Netw Open; 2022 Mar; 5(3):e223821. PubMed ID: 35319762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Social Determinants of Health and Continuity of Medications for Opioid Use Disorder Among Patients Receiving Treatment in Rural Primary Care Settings.
    Pham H; Ober A; Baldwin LM; Mooney LJ; Zhu Y; Fei Z; Hser YI
    J Addict Med; 2024 May-Jun 01; 18(3):331-334. PubMed ID: 38315721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations Between Distinct Co-occurring Substance Use Disorders and Receipt of Medications for Opioid Use Disorder in the Veterans Health Administration.
    Frost MC; Hawkins EJ; Glass JE; Hallgren KA; Williams EC
    J Addict Med; 2023 May-Jun 01; 17(3):278-285. PubMed ID: 37267168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings.
    Frost MC; Soyer EM; Achtmeyer CE; Hawkins EJ; Glass JE; Hallgren KA; Williams EC
    Addict Sci Clin Pract; 2023 May; 18(1):26. PubMed ID: 37143162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stakeholder perspectives on a telemedicine referral and coordination model to expand medication treatment for opioid use disorder in rural primary care clinics.
    Ober AJ; Dopp AR; Clingan SE; Curtis ME; Lin C; Calhoun S; Larkins S; Black M; Hanano M; Osterhage KP; Baldwin LM; Saxon AJ; Hichborn EG; Marsch LA; Mooney LJ; Hser YI
    J Subst Use Addict Treat; 2024 Jan; 156():209194. PubMed ID: 37863356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Availability of Medications for the Treatment of Opioid Use Disorder Among Pregnant and Postpartum Individuals in US Jails.
    Sufrin C; Kramer CT; Terplan M; Fiscella K; Olson S; Voegtline K; Latkin C
    JAMA Netw Open; 2022 Jan; 5(1):e2144369. PubMed ID: 35050354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of polysubstance use disorder with treatment quality among Medicaid beneficiaries with opioid use disorder.
    Smart R; Kim JY; Kennedy S; Tang L; Allen L; Crane D; Mack A; Mohamoud S; Pauly N; Perez R; Donohue J
    J Subst Abuse Treat; 2023 Jan; 144():108921. PubMed ID: 36327615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Access to Medications for Opioid Use Disorder in Rural Versus Urban Veterans Health Administration Facilities.
    Wyse JJ; Shull S; Lindner S; Morasco BJ; Gordon AJ; Carlson KF; Korthuis PT; Ono SS; Liberto JG; Lovejoy TI
    J Gen Intern Med; 2023 Jun; 38(8):1871-1876. PubMed ID: 36690913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities.
    Gordon AJ; Drexler K; Hawkins EJ; Burden J; Codell NK; Mhatre-Owens A; Dungan MT; Hagedorn H
    Subst Abus; 2020; 41(3):275-282. PubMed ID: 32697170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Care coordination between rural primary care and telemedicine to expand medication treatment for opioid use disorder: Results from a single-arm, multisite feasibility study.
    Hser YI; Mooney LJ; Baldwin LM; Ober A; Marsch LA; Sherman S; Matthews A; Clingan S; Fei Z; Zhu Y; Dopp A; Curtis ME; Osterhage KP; Hichborn EG; Lin C; Black M; Calhoun S; Holtzer CC; Nesin N; Bouchard D; Ledgerwood M; Gehring MA; Liu Y; Ha NA; Murphy SM; Hanano M; Saxon AJ
    J Rural Health; 2023 Sep; 39(4):780-788. PubMed ID: 37074350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies to recruit rural primary care providers to implement a medication for opioid use disorder (MOUD) focused integrated care model.
    Cloutier RM; Cole ES; McDonough BL; Lomauro DA; Miller JP; Talbert AL; Bear TM; Bridges NC; Foulds AL; Taber R; Gordon AJ; Cochran GT; Kmiec J; Donohue JM; Kelley D; DiDomenico E; Adair D; Pringle JL
    Implement Res Pract; 2023; 4():26334895231152808. PubMed ID: 37091535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Receipt of Opioid Use Disorder-Related Telehealth Services and Medications for Opioid Use Disorder With Fatal Drug Overdoses Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
    Jones CM; Shoff C; Blanco C; Losby JL; Ling SM; Compton WM
    JAMA Psychiatry; 2023 May; 80(5):508-514. PubMed ID: 36988913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of clinic switching and continuity of medication for opioid use disorder in a Medicaid-enrolled population.
    Cole ES; Drake C; DiDomenico E; Sharbaugh M; Kim JY; Nagy D; Cochran G; Gordon AJ; Gellad WF; Pringle J; Warwick J; Chang CH; Kmiec J; Kelley D; Donohue JM
    Drug Alcohol Depend; 2021 Apr; 221():108633. PubMed ID: 33631544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initiation and Receipt of Medication for Opioid Use Disorder Among Adolescents and Young Adults in 4 State Medicaid Programs in 2018: Improving Medicaid Quality Metrics.
    Lynch V; Clemans-Cope L
    Subst Use Addctn J; 2024 Jul; 45(3):434-445. PubMed ID: 38294428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racialized and beneficiary inequities in medication to treat opioid use disorder receipt within the US Military Health System.
    Lance Tippit T; O'Connell MA; Costantino RC; Scott-Richardson M; Peters S; Pakieser J; Tilley LC; Highland KB
    Drug Alcohol Depend; 2023 Dec; 253():111025. PubMed ID: 38006670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of military sexual trauma and gender on receipt of evidence-based medication treatment among veterans with opioid use disorder.
    Beckman KL; Williams EC; Hebert P; Hawkins EJ; Littman AJ; Lehavot K
    J Subst Abuse Treat; 2022 Aug; 139():108775. PubMed ID: 35317959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.